Month: January 2021

Why Evercell Bio chose VIPS: a new workflow for hiPSC in cell therapy

Philip D. Manos, Founder and President of EverCell Bio, Natick, Massachusetts, USA “Our mission is to accelerate the implementation of human and disease-specific stem cell technologies for drug discovery and personalized medicine” EverCell Bio is a single-source provider of customized services for the application of stem cell technology in cell therapy. EverCell offers human cell-modelling capabilities,... Continue reading: Why Evercell Bio chose VIPS: a new workflow for hiPSC in cell therapy